Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

NABP FPGEE Exam - Topic 2 Question 85 Discussion

Posted by Marge on Jun 28, 2024 at 05:02 PM

Mechanism of action of doxorubicin is:

Suggested Answer: E

Get Premium FPGEE Questions as Interactive Web-Based Practice Test or PDF Real Exam Format Detailed Explanations Instant Access Get Your Practice Test
37 comments · newest first
LO
Louisa 10 months ago
I thought it had something to do with GABA... am I wrong?
HA
Haley 11 months ago
Definitely not an alpha or beta antagonist!
CL
Clay 11 months ago
Wait, isn't it also a DNA intercalator?
LA
Lashunda 11 months ago
Totally agree, that's the main action!
LI
Lindy 11 months ago
Doxorubicin inhibits topoisomerase II, right?
MA
Marti 12 months ago
I don't recall doxorubicin enhancing GABAergic inhibition, so that option seems unlikely to me.
AN
Antonio 12 months ago
I’m a bit confused; I thought doxorubicin had something to do with beta antagonism, but that might be another drug.
SH
Shawna 12 months ago
I remember practicing a question about cancer drugs, and I think doxorubicin was mentioned as a topoisomerase inhibitor.
KA
Kasandra 1 year ago
I think doxorubicin works by inhibiting topoisomerase II, but I'm not completely sure.
TA
Tamesha 1 year ago
Ah, I remember now! Doxorubicin's primary mechanism is inhibiting topoisomerase II, which is essential for DNA unwinding and replication. That's definitely the best answer here.
ST
Stephaine 1 year ago
Wait, I'm getting a bit confused here. Doxorubicin has multiple mechanisms, right? I think it might also have some alpha or beta antagonist activity. I'll have to review my notes to be sure.
IR
Ira 1 year ago
Okay, let me see. Doxorubicin is an anthracycline antibiotic, so it likely interferes with DNA replication or transcription. I'm going to go with option A, inhibiting topoisomerase II.
HY
Hyman 1 year ago
Hmm, I'm a bit unsure about this one. I know doxorubicin is an antineoplastic agent, but I can't quite remember the specific mechanism. I'll have to think this through carefully.
VA
Val 1 year ago
I'm pretty confident that the mechanism of action of doxorubicin is inhibiting topoisomerase II, so I'll go with option A.
GL
Gladis 1 year ago
I think this question is asking about the section of the TOGAF document that covers the processes, skills, and roles needed to establish and operate an architecture function within an enterprise. Based on that, my best guess is that the answer is Part VII: Architecture Capability Framework.
GE
Gertude 1 year ago
Okay, I've got it! The policy dataset defines the IP addresses that are part of the "Admin_group". Then the responder policy "POL_1" blocks any traffic that doesn't come from those IP addresses. So option A is the correct answer.
EU
Eun 1 year ago
Wait, doxorubicin is an alpha blocker? That's just ridiculous. I'm going to have to go with the classic topoisomerase II inhibitor, A.
BE
Belen 1 year ago
↳ replying to Eun
I've also heard that doxorubicin works by inhibiting topoisomerase II. It's a well-known mechanism for this drug.
MA
Marge 1 year ago
↳ replying to Eun
Yeah, A is the correct answer. It's a common mechanism of action for doxorubicin.
LA
Lashandra 1 year ago
↳ replying to Eun
I agree, doxorubicin is definitely not an alpha blocker. Topoisomerase II inhibition makes more sense.
CA
Catarina 1 year ago
Hmm, allosterically enhancing GABA? That's just silly. This is clearly a cancer drug, not a central nervous system one. A has got to be the right answer here.
MO
Mona 1 year ago
Haha, beta antagonist? What is this, a cardiovascular exam? Definitely not D. I'm going to go with the topoisomerase II option, A.
AU
Audrie 1 year ago
↳ replying to Mona
Good choice, A is the correct answer for the mechanism of action of doxorubicin.
ME
Mel 1 year ago
↳ replying to Mona
Definitely not D, that's for sure. A is the right choice.
MA
Marlon 1 year ago
↳ replying to Mona
Yeah, that's right. Doxorubicin works by inhibiting topoisomerase II.
KI
Kimbery 1 year ago
↳ replying to Mona
I think A is correct, it inhibits topoisomerase II.
CH
Chun 1 year ago
Wait, isn't doxorubicin an antitumor antibiotic? I think it's got to be something related to DNA or protein synthesis. C - inhibits peptidyl transferase seems more plausible.
LA
Lashandra 2 years ago
Doxorubicin is a chemotherapy drug, so it's got to be inhibiting something important for cancer cells. I'm going with A - inhibits topoisomerase II. Sounds like the right mechanism to me.
DI
Dick 1 year ago
↳ replying to Lashandra
User4: Yeah, A) makes sense for a drug like doxorubicin
NO
Noelia 1 year ago
↳ replying to Lashandra
User3: I'm not sure, but I'll go with A) too
WI
Wilburn 1 year ago
↳ replying to Lashandra
User2: I agree, that seems like the right mechanism for a chemotherapy drug
SH
Sherell 1 year ago
↳ replying to Lashandra
User 2: Yeah, that makes sense for a chemotherapy drug.
AN
Annice 1 year ago
↳ replying to Lashandra
User 1: I think it inhibits topoisomerase II.
JU
Justine 1 year ago
↳ replying to Lashandra
User1: I think it's A) Inhibits topoisomerase II
NI
Nickolas 2 years ago
I'm not sure, but I think the correct answer is A) Inhibits topoisomerase II based on what I've studied.
ST
Steffanie 2 years ago
I agree with Jenelle, because doxorubicin is known to inhibit topoisomerase II which leads to DNA damage.
JE
Jenelle 2 years ago
I think the mechanism of action of doxorubicin is A) Inhibits topoisomerase II.
0/2000 characters

Save Cancel